Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

Nah, partner is paying for OM and IBD trials. Once milestones are hit we get milestone payments.

Kevetrin oral formulation and a phase 2a (10-20 patients) leading to a partnership will be more like $5-10 million. Partner it for big cash if it works.

B-ABSSSI likely on hold until more money is available. Likely an anti-infective partnership for ABSSSI, Acne, AD, and HS. Separates the platform into anti inflammatory and anti infective partitions.

Also, the company has never has $20 million on hand OR a phase 3 trial and still reached a market cap of around $480 million. $20-30 million + a phase 3 + third party validation could easily bring us back to there.